General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice, 1395 [2010-172]
Download as PDF
<![CDATA[
Federal Register / Vol. 75, No. 6 / Monday, January 11, 2010 / Notices
verified from the grantee records to
support the information outlined in the
FSR.
Failure to submit required reports
within the time allowed may result in
suspension or termination of an active
grant, withholding of additional awards
for the project, or other enforcement
actions such as withholding of
payments or converting to the
reimbursement method of payment.
Continued failure to submit required
reports may result in one or both of the
following: (1) The imposition of special
award provisions; and (2) the nonfunding or non-award of other eligible
projects or activities. This applies
whether the delinquency is attributable
to the failure of the grantee organization
or the individual responsible for
preparation of the reports.
C. FY 2007 and FY 2008 Single Audit
Reports (OMB A–133)
Applicants who have an active SDPI
grant are required to be up-to-date in the
submission of required audit reports.
These are the annual financial audit
reports required by OMB A–133, audits
of State, local governments, and nonprofit organizations that are submitted.
Documentation of (or proof of
submission) of current FY 2007 and FY
2008 Financial Audit Reports is
mandatory. Acceptable forms of
documentation include: e-mail
confirmation from FAC that audits were
submitted; or face sheets from audit
reports. Face sheets can be found on the
FAC Web site: https://harvester.census.
gov/fac/dissem/accessoptions.html?
submit=Retrieve+Records.
Telecommunication for the hearing
impaired is available at: TTY (301) 443–
6394.
srobinson on DSKHWCL6B1PROD with NOTICES
VII. Agency Contacts
• For Grants Budget Management,
contact:
• Denise Clark, Lead Grants
Management Specialist, DGO
(denise.clark@ihs.gov), Division of
Grants Operations, 801 Thompson
Avenue, TMP, Suite 360, Rockville, MD
20852. (301) 443–5204.
• For Grants.gov electronic
application process, contact:
• Tammy Bagley, Grants Policy, DGP
(tammy.bagley@ihs.gov), (301) 443–
5204. Grants Policy Web site: https://
www.ihs.gov/NonMedicalPrograms/
gogp/index.cfm?module=gogp_funding.
• For programmatic questions,
contact:
• Merle Mike, Program Assistant,
DDTP (merle.mike@ihs.gov), (505) 248–
4182.
VerDate Nov<24>2008
16:06 Jan 08, 2010
Jkt 220001
• Lorraine Valdez, Deputy Director,
DDTP (s.lorraine.valdez@ihs.gov), (505)
248–4182.
• Area Diabetes Consultants Web site:
https://www.ihs.gov/MedicalPrograms/
diabetes/index.cfm?module=peopleADC
Directory.
Dated: December 22, 2009.
Yvette Roubideaux,
Director, Indian Health Service.
[FR Doc. 2010–149 Filed 1–8–10; 8:45 am]
BILLING CODE 4165–16–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0606]
General and Plastic Surgery Devices
Panel of the Medical Devices Advisory
Committee; Amendment of Notice
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing an
amendment to the notice of a meeting of
the General and Plastic Surgery Devices
Panel of the Medical Devices Advisory
Committee. This meeting was
announced in the Federal Register of
November 17, 2009 (74 FR 59194). The
amendment is being made to reflect a
change in the Contact Person and
Procedure portions of the document,
and to provide notice of the availability
of a docket for public comment. There
are no other changes.
FOR FURTHER INFORMATION CONTACT:
Margaret McCabe-Janicki, Center for
Devices and Radiological Health, Food
and Drug Administration, 10903 New
Hampshire Ave., White Oak 66, rm.
1535, Silver Spring, MD 20993, 301–
796–7029, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area), code 3014512519. Please call the
Information Line for up-to-date
information on this meeting.
SUPPLEMENTARY INFORMATION: In FR Doc.
E9–27491, appearing on page 59194, in
the Federal Register of Tuesday,
November 17, 2009, the following
corrections are made:
1. On page 59194, in the second
column, under Contact Person, the first
six lines ‘‘Peter L. Hudson, Center for
Devices and Radiological Health, Food
and Drug Administration, 10903 New
Hampshire Ave., White Oak 66, rm.
3618, Silver Spring, MD 20993, 301–
796–6440 or FDA Advisory’’ are
removed and replaced with ‘‘Margaret
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
1395
McCabe-Janicki, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New Hampshire
Avenue., White Oak 66, rm. 1535, Silver
Spring, MD 20993, 301–796–7029, or
FDA Advisory’’.
2. On page 59194, in the third
column, a Comments portion is added
before the Agenda portion of the
document to read: ‘‘Comments: FDA is
opening a docket for public comment on
this document. The docket number is
FDA–2009–N–0606. The docket will
open for public comment on January 11,
2010. The docket will close on March
19, 2010. Interested persons may submit
electronic or written comments
regarding this document. Submit
electronic comments to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management, Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Submit a
single copy of electronic comments or
two paper copies of any mailed
comments, except that individuals may
submit one paper copy. Comments are
to be identified with the docket number
found in brackets in the heading of this
document. Received comments may be
seen in the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.’’
3. On pages 59194 and 59195,
beginning on page 59194 in the third
column, under Procedure, the year
‘‘2009’’ is changed to read ‘‘2010’’
everywhere that it appears.
This notice is issued under the
Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14,
relating to the advisory committees.
Dated: January 5, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy,
Planning and Budget.
[FR Doc. 2010–172 Filed 1–8–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Cardiovascular and Renal Drugs
Advisory Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 75, Number 6 (Monday, January 11, 2010)]
[Notices]
[Page 1395]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-172]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0606]
General and Plastic Surgery Devices Panel of the Medical Devices
Advisory Committee; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is announcing an
amendment to the notice of a meeting of the General and Plastic Surgery
Devices Panel of the Medical Devices Advisory Committee. This meeting
was announced in the Federal Register of November 17, 2009 (74 FR
59194). The amendment is being made to reflect a change in the Contact
Person and Procedure portions of the document, and to provide notice of
the availability of a docket for public comment. There are no other
changes.
FOR FURTHER INFORMATION CONTACT: Margaret McCabe-Janicki, Center for
Devices and Radiological Health, Food and Drug Administration, 10903
New Hampshire Ave., White Oak 66, rm. 1535, Silver Spring, MD 20993,
301-796-7029, or FDA Advisory Committee Information Line, 1-800-741-
8138 (301-443-0572 in the Washington, DC area), code 3014512519. Please
call the Information Line for up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In FR Doc. E9-27491, appearing on page
59194, in the Federal Register of Tuesday, November 17, 2009, the
following corrections are made:
1. On page 59194, in the second column, under Contact Person, the
first six lines ``Peter L. Hudson, Center for Devices and Radiological
Health, Food and Drug Administration, 10903 New Hampshire Ave., White
Oak 66, rm. 3618, Silver Spring, MD 20993, 301-796-6440 or FDA
Advisory'' are removed and replaced with ``Margaret McCabe-Janicki,
Center for Devices and Radiological Health, Food and Drug
Administration, 10903 New Hampshire Avenue., White Oak 66, rm. 1535,
Silver Spring, MD 20993, 301-796-7029, or FDA Advisory''.
2. On page 59194, in the third column, a Comments portion is added
before the Agenda portion of the document to read: ``Comments: FDA is
opening a docket for public comment on this document. The docket number
is FDA-2009-N-0606. The docket will open for public comment on January
11, 2010. The docket will close on March 19, 2010. Interested persons
may submit electronic or written comments regarding this document.
Submit electronic comments to https://www.regulations.gov. Submit
written comments to the Division of Dockets Management, Food and Drug
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified with the docket number found in brackets
in the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.''
3. On pages 59194 and 59195, beginning on page 59194 in the third
column, under Procedure, the year ``2009'' is changed to read ``2010''
everywhere that it appears.
This notice is issued under the Federal Advisory Committee Act (5
U.S.C. app. 2) and 21 CFR part 14, relating to the advisory committees.
Dated: January 5, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-172 Filed 1-8-10; 8:45 am]
BILLING CODE 4160-01-S
